Zero To 1(one), ZTI stands for developing new technologies that were never before. ZTI BIOSCIENCES, combining its very own original platform nanotechnology with biotech, is developing a next generation therapeutic radiopharmaceuticals for intractable & recurring solid cancers. ZTI, with the Nano Platform tech TERACARRIERTM, will bring a new paradigm of cancer care, unearthing the full potential of radioisotopes, standardizing radiopharmaceuticals, and providing innovative solutions for various indications in the area of intractable oncology.